Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. (Q36874626)
Jump to navigation
Jump to search
scientific article published on 17 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. |
scientific article published on 17 January 2013 |
Statements
Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure (English)
Acute Liver Failure Study Group
Sundeep Singh
William M Lee
17 January 2013
1 reference